Thermo Fisher Scientific | Pasivo Circulante



Current Liabilities Cambio Fecha
Abbott USD 14.16B 745M 2024-12
Agilent USD 1.87B 26M 2025-01
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Bio Techne USD 161.26M 19.13M 2024-12
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Bruker USD 1.28B 37.5M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Danaher USD 6.64B 153M 2025-03
Dentsply International USD 1.59B 47M 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
General Electric USD 34.94B 549M 2025-03
Henry Schein USD 2.8B 126M 2024-12
Hologic USD 1B 34.8M 2024-12
Illumina USD 1.55B 572M 2024-12
Intuitive Surgical USD 2.01B 200.9M 2025-03
IQVIA Holdings USD 6.96B 35M 2024-12
Laboratory Of America USD 3.33B 81.8M 2024-12
Medtronic USD 11.84B 355M 2025-01
Mettler Toledo International USD 1.17B 16.77M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Olympus JPY 414.56B 5.02B 2024-12
Quest Diagnostics USD 1.44B 728M 2025-03
Repligen USD 126.79M 18.42M 2024-12
Revvity USD 653.1M 34.84M 2024-12
Stryker USD 7.62B 53M 2024-12
Thermo Fisher Scientific USD 13.17B 158M 2025-03
Veracyte USD 78.63M 8.32M 2024-12
Waters USD 789.76M 26.28M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Thermo Fisher Scientific Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.